Colin Bennion

Design and Synthesis of a Novel and Potent Series of Inhibitors of Cytosolic Phospholipase A₂ Based on a 1,3-Disubstituted Propan-2-one Skeleton

Stephen Connolly, Colin Bennion, Sarah Botterell et al. · Journal of Medicinal Chemistry · 2002 · 84 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Novel <i>N</i>-Aryl and <i>N</i>-Heteroaryl Sulfamide Synthesis via Palladium Cross Coupling

Lilian Alcaraz, Colin Bennion, James Morris et al. · Organic Letters · 2004 · 53 citations

Natural Sciences, Chemistry, Catalysis +8

Discovery of new non-phospholipid inhibitors of the secretory phospholipases A2

Haydn G. Beaton, Colin Bennion, Stephen Connolly et al. · Journal of Medicinal Chemistry · 1994 · 48 citations · Full text

Medicine, Biochemistry, Pharmacology +8

Design and synthesis of some substrate analog inhibitors of phospholipase A2 and investigations by NMR and molecular modeling into the binding interactions in the enzyme-inhibitor complex

Colin Bennion, Stephen Connolly, Nigel P. Gensmantel et al. · Journal of Medicinal Chemistry · 1992 · 47 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

Hit-to-Lead studies: The discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists

Andrew Baxter, Colin Bennion, Janice Bent et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 46 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14